Recombinant Human Basic Fibroblast Growth Factor Uses, Dosage, Side Effects and more
| Trade Name | Recombinant Human Basic Fibroblast Growth Factor |
| Generic | Trafermin |
| Trafermin Other Names | Recombinant human basic fibroblast growth factor, rhbFGF, Trafermin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in coronary artery disease, peripheral vascular disease, periodontal disease, bone fractures, entero-related fistulae, and diabetic foot ulcers.
How Recombinant Human Basic Fibroblast Growth Factor works
Recombinant Human Basic Fibroblast Growth Factor, or basic fibroblast growth factor 2 (bFGF) is a recombinant human growth factor used to stimulate angiogenesis and keratinization in wound healing. It stimulates migration of monocytes, neutrophils, macrophages, fibroblasts and also assists in creation of granulation tissue (the tissue that replaces fibrin clots in healing wounds).
